119 related articles for article (PubMed ID: 1701816)
1. Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
Raponi G; Keller N; Overbeek BP; Rozenberg-Arska M; Torensma R; Verhoef J
J Infect Dis; 1991 Jan; 163(1):122-7. PubMed ID: 1701816
[TBL] [Abstract][Full Text] [Related]
2. Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli.
Raponi G; Lun MT; Lorino G; Nazzari C; Gaeta A; Mancini C; Filadoro F
J Antimicrob Chemother; 1993 Jan; 31(1):117-28. PubMed ID: 8444656
[TBL] [Abstract][Full Text] [Related]
3. Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli.
Lun MT; Raponi G; Amatucci AM; Natali PG; Fraioli R; Mancini C
J Med Microbiol; 1997 Feb; 46(2):122-8. PubMed ID: 9060871
[TBL] [Abstract][Full Text] [Related]
4. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
Lun MT; Amatucci AM; Raponi G; Filadoro F; Bartolazzi A; Fraioli R; Natali PG; Mancini C
J Med Microbiol; 1994 Sep; 41(3):179-83. PubMed ID: 8064837
[TBL] [Abstract][Full Text] [Related]
5. The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences.
Raponi G; Vreede RW; Rozenberg-Arska M; Hoepelman IM; Keller N; Verhoef J
J Antimicrob Chemother; 1989 Apr; 23(4):565-76. PubMed ID: 2663813
[TBL] [Abstract][Full Text] [Related]
6. Immunization of mice with antibiotic treated Escherichia coli.
Raponi G; Nazzari G; Lun MT; Lorino G; Valentini T; Bronzini M; Gaeta A; Mancini C; Filadoro F
J Chemother; 1991 Jan; 3 Suppl 1():136-40. PubMed ID: 12041748
[TBL] [Abstract][Full Text] [Related]
7. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor.
Wise AJ; Hogan JS; Takemura K; Smith KL
J Dairy Sci; 2003 Jan; 86(1):146-51. PubMed ID: 12613859
[TBL] [Abstract][Full Text] [Related]
8. Balance of proinflammatory and antiinflammatory cytokines in mice immunized with Escherichia coli and correlation with mortality after lethal challenge.
Raponi G; Ghezzi MC; Lun MT; Mancini C
Med Microbiol Immunol; 1998 Jun; 187(1):11-6. PubMed ID: 9749978
[TBL] [Abstract][Full Text] [Related]
9. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity.
Raponi G; Keller N; Rozenberg-Arska M; Lun MT; Mancini C; Verhoef J
Infect Immun; 1993 Sep; 61(9):3976-80. PubMed ID: 8359919
[TBL] [Abstract][Full Text] [Related]
11. Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.
Raponi G; Keller N; Overbeek BP; Rozenberg-Arska M; van Kessel KP; Verhoef J
Antimicrob Agents Chemother; 1990 Feb; 34(2):332-6. PubMed ID: 2109580
[TBL] [Abstract][Full Text] [Related]
12. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity.
Oishi K; Koles NL; Guelde G; Pollack M
J Infect Dis; 1992 Jan; 165(1):34-45. PubMed ID: 1727896
[TBL] [Abstract][Full Text] [Related]
14. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
[TBL] [Abstract][Full Text] [Related]
15. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
Siber GR; Kania SA; Warren HS
J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
[TBL] [Abstract][Full Text] [Related]
17. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
Bowden RA; Cloeckaert A; Zygmunt MS; Dubray G
J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948
[TBL] [Abstract][Full Text] [Related]
19. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
Veringa E; Box A; Rozenberg-Arska M; Verhoef J
Drugs Exp Clin Res; 1988; 14(1):1-8. PubMed ID: 3292179
[TBL] [Abstract][Full Text] [Related]
20. The influence of cefepime on opsonophagocytosis of bacteria.
Raponi G; Keller N; Rozenberg-Arska M; Hoepelman IM; Verhoef J
Drugs Exp Clin Res; 1989; 15(4):141-4. PubMed ID: 2673713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
